Research Tracker›Biomarker Atlas›Long COVID›TCA cycle intermediates

TCA cycle intermediates in Long COVID

In Long COVID (PASC, Post-Acute Sequelae of COVID-19), published studies report higher levels of TCA cycle intermediates, also described as Succinate, citrate, etc., than in recovered individuals without persistent symptoms (fully recovered). Clinically, it has been associated with mitochondrial dysfunction. The finding is drawn from Pérez-Mazliah et al. 2024; it describes group-level differences, not a threshold that classifies an individual.

↑ ElevatedMetabolic

Summary

Direction in Long COVID↑ Elevated — higher than in the comparison group
CategoryMetabolic
Also described asSuccinate, citrate, etc.
Compared againstR (fully recovered) (recovered individuals without persistent symptoms (fully recovered))
Associated symptomsMitochondrial dysfunction
Test typeBlood test (serum / plasma / whole blood)
SourcePérez-Mazliah et al. 2024 — doi:10.1021/acs.jproteome.3c00706
Condition atlasLong COVID Biomarker Atlas

Trials, interventions and tests

In clinical-trial registrations this marker maps to the outcome term Change in 6 Minute Walk Test at the End of Treatment Period (3 registered trials use a matching outcome measure).

Clinical trials using TCA cycle intermediates as an outcome

Related Metabolic markers in Long COVID

Full list: Long COVID Biomarker Atlas.

Frequently asked questions

Is TCA cycle intermediates high or low in Long COVID?

Elevated. Studies summarised in the OSMF atlas report higher TCA cycle intermediates in Long COVID than in recovered individuals without persistent symptoms (fully recovered). Source: Pérez-Mazliah et al. 2024.

What symptoms is TCA cycle intermediates associated with in Long COVID?

The cited literature associates this marker with Mitochondrial dysfunction. These are population-level associations and do not mean the marker causes the symptoms.

Which test measures TCA cycle intermediates?

It is measured as a blood test (serum / plasma / whole blood). Many of the cited studies used research-grade assays, so clinical availability may vary.

Is one abnormal TCA cycle intermediates result diagnostic of Long COVID?

No. No single biomarker is diagnostic of Long COVID. TCA cycle intermediates findings come from group comparisons, overlap considerably between patients and controls, and vary with study design, timing and comparison group. A result should be interpreted by a clinician alongside symptoms, history and other tests.

Cite this page

Open Source Medicine Foundation. (2026). TCA cycle intermediates in Long COVID: direction, evidence and what it means. OSMF Research Tracker. Retrieved October 7, 2026, from https://research.opensourcemed.info/biomarkers/long-covid/tca-cycle-intermediates.html
Get OSMF research updates. New biomarker, trial and treatment evidence summaries by email.
Subscribe on Substack

Last reviewed: 2026-06-29 · Page generated from long-covid.json · Browse: Long COVID atlas · Biomarker Index · All marker pages

Disclaimer: This page is an educational synthesis of published, peer-reviewed research and is not medical advice. Biomarker findings vary across studies with case definitions, comparison groups, timing and assay methods. Direction of change reflects the predominant finding in the cited source and does not establish a diagnostic threshold. Discuss any test result with a qualified clinician.